United States of America: Federal Trade Commission approved settlement with NextMed over deceptive online advertising

On 3 December 2025, the Federal Trade Commission (FTC) approved a settlement with telemedicine company NextMed over charges that it had used deceptive claims and fake reviews and testimonials in advertising. NextMed disseminated advertisements using online banners, paid search advertisements, and social media advertisements on sites such as YouTube and Facebook. Under the terms of the consent order, NextMed is prohibited from making misrepresentations about its telehealth services and must pay USD 150'000 to the FTC, intended to provide customer refunds.